데이터가 없습니다.

1. Evaluating amikacin minimum inhibitory concentration in trailing growth for Mycobacterium avium complex [ TUBERCULOSIS ] - 2023.12.01
2. Treatment outcome, recurrence and safety of multidrug-resistant TB treated with low-dose linezolid [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2023.12.01
3. A prospective patient registry to monitor safety, effectiveness, and utilisation of bedaquiline in patients with multidrug-resistant tuberculosis in South Korea [ BMC INFECTIOUS DISEASES ] - 2023.01.09
4. Treatment outcomes of multidrug-resistant TB with selective use of new drugs [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2023.01.01
5. Treatment outcomes of multidrug-resistant tuberculosis with chronic kidney/liver disease [ EUROPEAN RESPIRATORY JOURNAL ] - 2022.08.10
6. Safety of latent tuberculosis infection treatment in older patients with immune-mediated inflammatory diseases [ CLINICAL RHEUMATOLOGY ] - 2022.03.01
7. Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patientswith Pulmonary Tuberculosis [ ANTIMICROBIAL AGENTS AND CHEMOTHERAPY ] - 2022.02.15
8. Performance Assessment of Xpert MTB/RIF Assay for Detecting Pulmonary Tuberculosis and Rifampin Resistance in a Tertiary Care Hospital in Korea [ JAPANESE JOURNAL OF INFECTIOUS DISEASES ] - 2021.12.01
9. Outcomes of Multidrug-Resistant Tuberculosis Treated With Bedaquiline or Delamanid [ CLINICAL INFECTIOUS DISEASES ] - 2021.10.20
10. Impact of revised definitions for extensively drug-resistant TB on disease classification [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2021.09.01
11. Evaluation of a lateral flow assay-based IFN-gamma release assay as a point-of-care test for the diagnosis of latent tuberculosis infection [ CLINICAL RHEUMATOLOGY ] - 2021.09.01
12. Cavity formation and its predictors in noncavitary nodular bronchiectatic Mycobacterium avium complex pulmonary disease [ RESPIRATORY MEDICINE ] - 2021.04.01
13. Concurrent use of bedaquiline and delamanid for the treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis: a nationwide cohort study in South Korea [ EUROPEAN RESPIRATORY JOURNAL ] - 2021.03.04
14. Impact of Molecular Drug Susceptibility Testing on the Time to Multidrug-resistant Tuberculosis Treatment Initiation [ JOURNAL OF KOREAN MEDICAL SCIENCE ] - 2020.09.07
15. Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid [ INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES ] - 2020.09.01
16. Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection [ PLOS ONE ] - 2020.06.16
17. Interim Treatment Outcomes in Multidrug-Resistant Tuberculosis Using Bedaquiline and/or Delamanid in South Korea [ RESPIRATORY MEDICINE ] - 2020.06.01
18. QuantiFERON-TB Gold PLUS versus QuantiFER-ON-TB Gold In-Tube test for diagnosing tuberculosis infection [ KOREAN JOURNAL OF INTERNAL MEDICINE ] - 2020.03.01
19. Treatment outcomes in multidrug-resistant tuberculosis according to pyrazinamide susceptibility [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2020.02.01
20. Early Discontinuation of Ethambutol in Pulmonary Tuberculosis Treatment Based on Results of the GenoType MTBDRplus Assay: a Prospective, Multicenter, Noninferiority Randomized Trial in South Korea [ ANTIMICROBIAL AGENTS AND CHEMOTHERAPY ] - 2019.12.15
21. Adverse event and treatment completion rates of a 12-dose weekly isoniazid and rifapentine course for South Korean healthcare workers [ RESPIRATORY MEDICINE ] - 2019.10.15
22. Long-Term Outcomes of Adult Lung Transplantation Recipients: A Single-Center Experience in South Korea [ Tuberculosis and Respiratory Diseases(결핵 및 호흡기질환) ] - 2019.10.01
23. Concurrent, Prolonged Use of Bedaquiline and Delamanid for Multidrug-Resistant Tuberculosis. [ 대한내과학회지 ] - 2019.06.01
24. Correlation between GenoType MTBDRplus Assay and Phenotypic Susceptibility Test for Prothionamide in Patients with Genotypic Isoniazid Resistance. [ Tuberculosis and Respiratory Diseases(결핵 및 호흡기질환) ] - 2019.04.01
25. Successful Treatment with a High-dose Rifampin-containing Regimen for Pulmonary Tuberculosis with a Disputed rpoB Mutation [ INTERNAL MEDICINE ] - 2018.11.15
26. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease. [ RESPIRATORY MEDICINE ] - 2017.12.01
27. Performance of the GenoType MTBDRsl assay for the detection second-line anti-tuberculosis drug resistance [ JOURNAL OF INFECTION AND CHEMOTHERAPY ] - 2017.12.01
28. Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis. [ RESPIRATORY MEDICINE ] - 2017.10.01
29. Clinical significance of QT-prolonging drug use in patients with MDR-TB or NTM disease. [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2017.09.01
30. Frequency and Type of Disputed rpoB Mutations in Mycobacterium tuberculosis Isolates from South Korea [ Tuberculosis and Respiratory Diseases ] - 2017.07.01
31. Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea. [ Tuberculosis and Respiratory Diseases(결핵 및 호흡기질환) ] - 2017.04.01
32. Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course. [ EUROPEAN RESPIRATORY JOURNAL ] - 2017.03.08
33. Analysis of discrepant results between the Genotype® MTBDRplus assay and an antimicrobial-susceptibility test for isoniazid-resistant tuberculosis [ RESPIRATORY MEDICINE ] - 2017.01.01
34. Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients. [ TRANSPLANT INTERNATIONAL ] - 2016.05.01
35. Adequacy of initiating TNF antagonists within 3 weeks of starting latent tuberculosis infection treatment in patients with immune-mediated inflammatory diseases. [ Infectious diseases ] - 2016.04.01
36. Comparison of latent tuberculosis infection rate between contacts with active tuberculosis and non-contacts. [ RESPIRATORY MEDICINE ] - 2016.02.01
37. Mycobacterium massiliense Type II genotype leads to higher level of colony forming units and TNF-α secretion from human monocytes than Type I genotype [ APMIS ] - 2015.10.01
38. Performance of REBA MTB-XDR to detect extensively drug-resistant [ JOURNAL OF INFECTION AND CHEMOTHERAPY ] - 2015.05.01
39. Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2015.03.01
40. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease [ RESPIRATORY MEDICINE ] - 2014.11.01
41. Mycobacterial diseases developed during anti-tumour necrosis factor-α therapy [ EUROPEAN RESPIRATORY JOURNAL ] - 2014.11.01
42. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay [ SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES ] - 2014.11.01
43. Treatment outcomes of refractory MAC pulmonary disease treated with drugs with unclear efficacy. [ JOURNAL OF INFECTION AND CHEMOTHERAPY ] - 2014.10.01
44. Diagnosis and Treatment of Latent Tuberculosis Infection due to Initiation of Anti-TNF Therapy [ Tuberculosis and Respiratory Diseases(결핵 및 호흡기질환) ] - 2014.06.01
45. The ‘either test positive’ strategy for latent tuberculous infection before anti-tumour necrosis factor treatment [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2014.04.01
46. Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen [ RESPIRATORY MEDICINE ] - 2014.04.01
47. Treatment outcomes and moxifloxacin susceptibility in ofloxacin-resistant multidrug-resistant tuberculosis [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2014.01.01
48. Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy [ Intestinal Research ] - 2014.01.01
49. Impact of Diabetes on Treatment Outcomes and Long-Term Survival in Multidrug-Resistant Tuberculosis [ RESPIRATION ] - 2013.12.15
50. Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis. [ RESPIRATORY MEDICINE ] - 2013.11.01
51. The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosis [ RESPIRATORY MEDICINE ] - 2013.02.15
52. GenoType (R) MTBDRplus assay detection of drug-resistant tuberculosis in routine practice in Korea [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2013.01.01
53. Combined use of a TST and the T-SPOT®.TB assay for latent tuberculosis infection diagnosis before anti-TNF-𝛂 treatment [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2012.10.01
54. Poor correlation between tuberculin skin tests and interferon-gamma assays in close contacts of patients with multidrug-resistant tuberculosis [ RESPIROLOGY ] - 2012.10.01
55. Prevalence of Latent Tuberculosis Infection among Medical Students in South Korea [ Tuberculosis and Respiratory Diseases ] - 2012.10.01
56. Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients [ JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY ] - 2012.06.01
57. Increasing Trend of Isolation of Non-Tuberculous Mycobacteria in a Tertiary University Hospital in South Korea [ Tuberculosis and Respiratory Diseases ] - 2012.05.01
58. Disseminated Mycobacterium intracellulare Infection in an Immunocompetent Host [ Tuberculosis and Respiratory Diseases ] - 2012.05.01
59. 잠복결핵감염의 진단과 치료 [ 대한내과학회지 ] - 2012.03.01
60. Chest Computed Tomography Is More Likely to Show Latent Tuberculosis Foci Than Simple Chest Radiography in Liver Transplant Candidates [ LIVER TRANSPLANTATION ] - 2011.08.01
61. Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2011.05.01
62. Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs [ RESPIRATORY MEDICINE ] - 2011.05.01
63. Treatment Outcome and Mortality among Patients with Multidrug-resistant Tuberculosis in Tuberculosis Hospitals of the Public Sector [ JOURNAL OF KOREAN MEDICAL SCIENCE ] - 2011.01.01
64. Non-tuberculous mycobacterial diseases presenting as solitary pulmonary nodules [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2010.12.01
65. 심장이식 환자에서 발생한 비결핵항산균 폐질환 2예 [ Tuberculosis and Respiratory Diseases ] - 2010.09.01
66. 국내 민간병원에서 치료한 다제내성결핵 환자의 치료 결과 및 예후 인자 [ Tuberculosis and Respiratory Diseases ] - 2010.08.01
67. Living-donor liver transplantation in patients with concurrent active tuberculosis at transplantation [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2010.08.01
68. Treatment Outcomes and Survival Based on Drug Resistance Patterns in Multidrug-resistant Tuberculosis [ AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE ] - 2010.07.01
69. 국내 다제내성 및 광범위내성결핵의 최근 현황 [ Tuberculosis and Respiratory Diseases(결핵 및 호흡기질환) ] - 2010.03.31
70. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak [ RESPIRATORY MEDICINE ] - 2010.03.17
71. Elevated serum CA-125 levels in patients with non-tuberculous mycobacterial lung disease [ RESPIROLOGY ] - 2010.02.01
72. 레지오넬라 폐렴과 폐렴구균 폐렴 환자의 임상 양상에 대한 비교 [ Tuberculosis and Respiratory Diseases ] - 2010.02.01
73. 18F-FDG Positron Emission Tomography in Patients with Concomitant Malignancy and Tuberculoma [ Tuberculosis and Respiratory Diseases(결핵 및 호흡기질환) ] - 2010.01.31
74. Bronchopleural fistula treated with a silicone-covered bronchial occlusion stent. [ ANNALS OF THORACIC SURGERY ] - 2010.01.01
75. Annual Incidence of Latent Tuberculosis Infection among Newly Employed Nurses at a Tertiary Care University Hospital [ INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY ] - 2009.12.15
76. 베체트병 포도막염 환자에서 Infliximab 사용 중 발생한 속립성 결핵 1예 [ 결핵 및 호흡기질환 ] - 2009.11.30
77. Pneumocystis jiroveci Pneumonia Mimicking Miliary Tuberculosis in a Kidney Transplanted Patient [ 결핵 및 호흡기질환 ] - 2009.08.31
78. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis [ JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY ] - 2009.08.01
79. 면역 저하 환자에서 발생한 파종성 Mycobacterium intracellulare 감염 1예 [ 결핵 및 호흡기질환 ] - 2009.07.31
80. Combined use of QuantiFERON (R)-TB Gold assay and chest computed tomography in a tuberculosis outbreak [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2009.04.15
81. A case of Mycobacterium avium Lung disease complicating chronic pulmonary thromboembolism [ 대한내과학회지 ] - 2009.01.01
82. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis [ INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS ] - 2009.01.01
83. Pulmonary tuberculosis with acute respiratory failure [ EUROPEAN RESPIRATORY JOURNAL ] - 2008.10.11
84. Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. [ AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE ] - 2008.08.01
85. 마우스 결핵 모델에서 Isoniazid를 제외한 표준치료의 예비 연구 [ 대한결핵및호흡기학회 ] - 2008.01.01
86. A case of false-positive multidrug-resistant tuberculosis confirmed by restriction ragment length polymorphism [ The Korean Journal of Internal Medicine ] - 2008.01.01
87. Evaluation of therapeutic response of tuberculoma using F-18 FDG Positron Emission tomography. [ JOURNAL OF NUCLEAR MEDICINE ] - 2008.01.01
88. Incidence of tuberculosis among health care workers at a private university hospital in Korea. [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2008.01.01
89. 국내에서 잠복결핵의 치료 [ 결핵 및 호흡기질환 ] - 2008.01.01
90. Mycobacterium abscessus 폐질환 치료의 장기성적 [ 결핵 및 호흡기질환 ] - 2007.11.09
91. Long-term outcome of treatment of Mycobacterium abscessus pulmonary disease [ 결핵 및 호흡기질환 ] - 2007.10.11
92. 폐결핵 환자의 말초 혈액에서 중합효소연쇄반응을 이용한 결핵균 DNA의 검출 [ 결핵 및 호흡기질환 ] - 2007.09.13
93. Impact of short-term exposure to fluoroquinolones on ofloxacin resistance in HIV-negative patients with tuberculosis [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2007.03.01
94. 간 또는 심장이식을 시행 받은 환자에서의 결핵의 발생률 및 임상양상 [ 대한결핵및호흡기학회 ] - 2006.11.30
95. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis [ JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY ] - 2006.09.01
96. Comparison of two commercial interferon-r assays for diagnosing Mycobacterium tuberculosis infection [ EUROPEAN RESPIRATORY JOURNAL ] - 2006.06.30
97. 체외 Interferon-gamma 검사를 이용한 결핵감염의 진단 [ 대한결핵및호흡기학회 ] - 2006.05.31
98. 폐종괴와 기관지 탄분섬유화로 발현한 Mycobacterium kansasii 감염 1예 [ 대한결핵및호흡기학회 ] - 2006.04.30
99. 치료 완료 까지 지속되었다가 치료 완료 후 호전된 종양형 기관지결핵 1예 [ 대한결핵및호흡기학회 ] - 2006.03.31
100. 다제내성 결핵에 의한 횡단척수염 1예 [ 대한결핵및호흡기학회 ] - 2006.03.31
101. 국내 한 민간종합병원에서 결핵 환자의 진료 실태 [ 대한결핵및호흡기학회 ] - 2006.02.28
102. 한국인 폐결핵 환자의 표준치료에서 Isoniazid 300 mg 및 400 mg의 치료 효과와 부작용의 비교 [ 대한결핵및호흡기학회 ] - 2006.01.31
103. Isoniazid를 제외한 Rifampicin과 Pyrazinamide 병합치료의 간독성 빈도. [ 대한결핵및호흡기학회 ] - 2006.01.27
104. 검사가 결핵에 대한 체외 IFN-g 검사 결과에 미치는 영향 [ 결핵 및 호흡기질환 ] - 2005.10.01
105. 국내 한 민간종합병원에서 결핵 환자의 진단 및 치료 실태 [ 가정의학회지 ] - 2005.08.25
106. 균집락수가 적은 암색소성 비결핵항산균 배양의 임상적 의미. [ 대한결핵및호흡기학회 ] - 2005.07.01
107. 객담 항산균 도말 양성 환자에서 비결핵항산균과의 감별을 위한 결핵균 중합효소연쇄반응 검사의 유용성. [ 대한결핵및호흡기학회 ] - 2005.05.02
108. 한 대학병원에서 비결핵항산균의 분리 및 동정 실태 [ 결핵 및 호흡기질환 ] - 2005.04.01
109. 국내에서 잠복결핵의 진단 및 치료 [ 결핵 및 호흡기질환 ] - 2004.03.01
110. 원인 미상으로 Chylothorax와 Chyluria가 병발한 1예 [ 결핵 및 호흡기질환 ] - 2004.03.01
111. 쿠싱병에 동반된 폐 노카르디아증 1예 [ 결핵 및 호흡기질환 ] - 2004.03.01
112. 기관지확장증 환자에서 폐비결핵성 마이코박테리아증의 유병율 [ 결핵 및 호흡기질환 ] - 2004.03.01
113. 내독소로 유도되는 급성폐손상의 발병기전에서 내인성 히스타민의 역할 [ 결핵 및 호흡기질환 ] - 2003.03.01
114. 신속발육비결핵항산균에 의한 폐감염의 임상상 [ 결핵 및 호흡기질환 ] - 2003.03.01
115. Dynamics of Macrophage Cell Populations During Murine Pulmonary Tuberculosis [ ] - 2003.03.01
116. Effect of alveolar recruitment maneuver in early acute respiratory distress syndrome according to antiderecruitment startegy, etiological category of diffuse lung injury, and body position of the pati [ CRITICAL CARE MEDICINE ] - 2003.02.01
117. Adequately washed bronchoscope does not induce false-positive amplification tests on bronchial aspirates in the diagnosis of pulmonary tuberculosis [ CHEST ] - 2002.03.01

1. [정책연구] 다제내성결핵 치료 신약 사용 적정성 평가 - 2023.04.17 ~ 2023.12.15
2. [정책연구] 다제내성결핵 치료 신약 사용 적정성 정량 지표 개발 및 평가 - 2022.05.23 ~ 2022.12.15
3. 퀴놀론 내성 다제내성결핵 환자 치료에서 6개월 BPaL 치료제 효과_ 다기관, 단일군, 운영연구 임상시험 - 2022.03.07 ~ 2027.12.31
4. 잠복 또는 활동성 결핵 환자의 PBMC를 이용한 결핵 예방_치료 백신 후보물질 NexaPep-TB의 세포성 면역반응의 검증 - 2022.01.25 ~ 2022.12.31
5. 잠복 및 활동성 결핵 동시 진단 현장검사법 개발 - 2022.01.01 ~ 2022.12.31
6. 제도개선에 따른 다제내성결핵 신약 분석 및 관리방안 연구 - 2021.05.03 ~ 2021.12.15
7. QMACDST의 정확도 및 임상 적용 평가를 위한 다기관 임상시험 - 2021.01.01 ~ 2022.12.31
8. 잠복 및 활동성 결핵 동시 진단 현장검사법을 이용한 임상시험 - 2021.01.01 ~ 2021.12.31
9. 다제내성결핵 최적 치료를 위한 체계 구축 및 운영 - 2020.04.24 ~ 2020.12.31
10. 잠복 및 활동성 결핵 동시 진단 현장검사법을 이용한 임상시험 - 2020.04.23 ~ 2020.12.31
11. QMAC-DST의 정확도 및 임상 적용 평가를 위한 다기관 임상시험 - 2020.02.01 ~ 2020.12.31
12. QMAC-DST의 정확도 및 임상 적용 평가를 위한 다기관 임상시험 - 2019.05.17 ~ 2020.01.31
13. 다제내성결핵 신약 사용 적정화 방안 마련 - 2019.03.19 ~ 2020.01.18
14. 결핵감염 키트 개발을 위한 임상 연구 - 2019.01.01 ~ 2019.12.31
15. 비낭성 섬유증 기관지확장증 시험대상자에서 24주간 INS1007 1일 1회 투여의 유효성, 안전성과 내약성 및 약동학을 평가하는 무작위 배정, 이중 눈가림, 위약 대조, 평행군, - 2018.03.05 ~ 2020.01.14
16. 다제내성결핵 신약 단일심사제 전환 평가 - 2018.02.01 ~ 2018.12.31
17. 결핵감염 키트 개발을 위한 임상 연구 - 2018.01.01 ~ 2018.12.31
18. 진공채혈관으로 채혈된 사람의 전혈(헤파린)에서 형광면역분석법(Fluorescence immunoassay FIA)을 이용하여 결핵균 특이항원에 의해 반응된 인터페론 감마(IFN-gamma)를 정성하여 결핵균 감염여부 진단에 도움을 주는 임상시험용 의료기기인 “ichroma™ IGRA-TB”와 비교 - 2017.11.13 ~ 2019.12.31
19. 다제내성결핵 신약 사전심사제 운영 평가(1) - 2017.06.21 ~ 2017.12.20
20. 결핵감염 키트 개발을 위한 임상 연구 - 2017.04.10 ~ 2017.12.31
21. Mycobacterium avium complex(MAC)로 유발된 치료에 불응성인 비결핵 항산균 (NTM) 폐 감염 성인 환자를 대상으로 한 흡입용 리포좀화 아미카신(LAI)의 다기관 시험에 대한 공개 안전성 연장 임상시험 - 2017.01.31 ~ 2019.07.31
22. 객담항산균도말양성 폐결핵 성인환자를 대상으로 경구 투여된 LCB01-0371의 Early bactericidal activity (EBA), 안전성 및 약동학을 평가하기 위한 전향적, 무작위 배정, 공개, 실약 대조, 다기관, 중재적, 탐색적 2상 임상시험 - 2016.06.09 ~ 2017.06.30
23. Mycobacterium avium complex(MAC)로 유발된 치료에 불응성인 비결핵 항산균(NTM) 폐 감염 성인 환자를 대상으로 한 흡입용 리포좀화 아미카신(LAI)의 무작위 배정, 공개, 다기관 시험. - 2016.05.16 ~ 2019.07.31
24. 퀴놀론감성 다제내성결핵 환자 치료 시 delamanid, linezolid, levofloxacin, pyrazinamide 요법의 효과: 다기관, 무작위배정, 약명공개, 제2상 임상시험(다제내성결핵 치료단축 연구) - 2016.04.05 ~ 2019.12.31
25. 항산균 도말 양성 폐결핵 환자에서 신속감수성검사에 근거한 3제 표준치료의 유용성 - 2014.07.02 ~ 2015.07.01
26. 입원명령 결핵환자 지원사업 평가 및 개선방안 모색 - 2013.12.24 ~ 2014.05.23
27. 항산균 도말 양성 폐결핵 환자에서 신속감수성검사에 근거한 3제 표준치료의 유용성 - 2013.07.02 ~ 2014.07.01
28. 활동성 결핵 환자에서 퀴놀론 항생제의 사용 현황, 치료효과 및 안정성 - 2012.08.24 ~ 2013.12.31
29. 다제 내성 결핵 (MDR-­TB)의 객담 도말­양성 폐 감염이 있는 피험자에서 TMC207의 유효성 및 안전성을 평가하기 위한 제 III상 위약 대조, 이중맹검, 무작위 배정 임상시험 - 2012.07.20 ~ 2018.12.31
30. 항상균 도말 양성 폐결핵 환자에서 신속감수성검사에 근거한 3제 표준치료의 유용성 - 2012.07.02 ~ 2013.07.01
31. 다제내성결핵에서 흡입 Nitric oxide치료효과 및 NRAMP1유전자 다형성에 관한 연구 - 1999.12.01 ~ 2000.11.30
32. 다제약제내성결핵에서 rifabutin 치료효과에 대한 임상적 고찰 및 rpoB 유전자 돌연변이 양상의 비교연구 - 1998.12.01 ~ 1999.11.30

데이터가 없습니다.

      데이터가 없습니다.

 공지